Dr. Sadeghi is originally from Iran and received his initial medical training at the Tehran University of Medical Sciences. As an internal medicine faculty at UT Houston, he became interested in cancer care and completed his fellowship in Hematology-Oncology at the University of Texas Southwestern Medical Center. Dr. Sadeghi brings to UTSW a strong background in breast medical oncology, malignant hematology, and medical education. He currently specializes in breast cancer and hematologic malignancies. His clinical practice emphasizes patient and family-centered care.
|Medical School||Tehran University of Medical Sciences Medical School (1999)|
|Other Post Graduate Training||University of Texas Health Science Center at Houston (2004)|
|Internship||University of Texas Medical School Department of Medicine (2005), Internal Medicine|
|Residency||University of Texas Medical School Department of Medicine (2007), Internal Medicine|
|Undergraduate School||University of Texas School of Public Health (2010), Epidemiology|
|Fellowship||UT Southwestern Medical Center Hema Onco Fellowship (2013), Hematology & Oncology|
- Breast cancer
- Cancer and diabetes
- Targeted therapies in breast cancer
- Targeting the PI3K pathway for cancer therapy.
- Sadeghi N, Gerber DE Future Med Chem 2012 Jun 4 9 1153-69
- Metformin use is associated with better survival of diabetic patients with pancreatic cancer.
- Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D Clin. Cancer Res. 2012 May 18 10 2905-12
- American College of Clinical Oncology (2010)
- American Society of Hematology (2010)
- American College of Physicians (2004)
- American Medical Association (2004)